aluates Reports

$ 0.0

Automative

Global Next-Generation Drug-Eluting Stent Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-15Z4316

Global Next Generation Drug Eluting Stent Market Insights and Forecast to 2028

BUY CHAPTERS

Global Next-Generation Drug-Eluting Stent Market Research Report 2025

Code: QYRE-Auto-15Z4316

Report

August 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott

Biosensors International

Next-Generation Drug-Eluting Stent Market

The global market for Next-Generation Drug-Eluting Stent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Next-generation drug-eluting stent is advantageous as it offers improved deliverability by using materials like cobalt chromium, cobalt nickel, and cobalt alloy, this results in significant reduction in strut width, and enhance stent flexibility. In next-generation drug eluting stent, several drugs are coated in stents to address multiple restenosis pathways by altering drug release kinetics that mimics restenosis cascade. In addition, next-generation drug-eluting stent utilizes bioabsorbable polymers to reduce complications of late stent thrombosis, and bioresorbable drug-eluting scaffold plays a vital role in transforming coronary artery disease treatment.

The market in North America is anticipated to show the largest market share for the next-generation drug-eluting stent, followed by Europe, owing to the high prevalence and incidence of coronary artery disease. In addition, presence sophisticated healthcare infrastructure, and well-trained healthcare professionals are also impelling the growth of next-generation drug eluting stent market. The market in Asia-Pacific region is estimated to grow at fastest CAGR over the forecast period owing to increasing investment from both public and private bodies and improving healthcare facilities. However, market in the Middle East & Africa shows the steady growth during the forecast period.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Next-Generation Drug-Eluting Stent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Drug-Eluting Stent.

The Next-Generation Drug-Eluting Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Next-Generation Drug-Eluting Stent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Next-Generation Drug-Eluting Stent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Next-Generation Drug-Eluting Stent Market Report

Report Metric	Details
Report Name	Next-Generation Drug-Eluting Stent Market
Segment by Type	Cobalt Chromium Stainless Steel Others
Segment by Application	Hospitals Clinics Ambulatory Surgical Centers
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abbott, Biosensors International, Medtronic, Sorin Group, SMT, Terumo
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Next-Generation Drug-Eluting Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Next-Generation Drug-Eluting Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Next-Generation Drug-Eluting Stent Market report?

Ans: The main players in the Next-Generation Drug-Eluting Stent Market are Abbott, Biosensors International, Medtronic, Sorin Group, SMT, Terumo

What are the Application segmentation covered in the Next-Generation Drug-Eluting Stent Market report?

Ans: The Applications covered in the Next-Generation Drug-Eluting Stent Market report are Hospitals, Clinics, Ambulatory Surgical Centers

What are the Type segmentation covered in the Next-Generation Drug-Eluting Stent Market report?

Ans: The Types covered in the Next-Generation Drug-Eluting Stent Market report are Cobalt Chromium, Stainless Steel, Others

1 Next-Generation Drug-Eluting Stent Market Overview

1.1 Product Definition

1.2 Next-Generation Drug-Eluting Stent by Type

1.2.1 Global Next-Generation Drug-Eluting Stent Market Value Comparison by Type (2024 VS 2031)

1.2.2 Cobalt Chromium

1.2.3 Stainless Steel

1.2.4 Others

1.3 Next-Generation Drug-Eluting Stent by Application

1.3.1 Global Next-Generation Drug-Eluting Stent Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Ambulatory Surgical Centers

1.4 Global Next-Generation Drug-Eluting Stent Market Size Estimates and Forecasts

1.4.1 Global Next-Generation Drug-Eluting Stent Revenue 2020-2031

1.4.2 Global Next-Generation Drug-Eluting Stent Sales 2020-2031

1.4.3 Global Next-Generation Drug-Eluting Stent Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Next-Generation Drug-Eluting Stent Market Competition by Manufacturers

2.1 Global Next-Generation Drug-Eluting Stent Sales Market Share by Manufacturers (2020-2025)

2.2 Global Next-Generation Drug-Eluting Stent Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Next-Generation Drug-Eluting Stent Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Next-Generation Drug-Eluting Stent, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Next-Generation Drug-Eluting Stent, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Next-Generation Drug-Eluting Stent, Product Type & Application

2.7 Global Key Manufacturers of Next-Generation Drug-Eluting Stent, Date of Enter into This Industry

2.8 Global Next-Generation Drug-Eluting Stent Market Competitive Situation and Trends

2.8.1 Global Next-Generation Drug-Eluting Stent Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Next-Generation Drug-Eluting Stent Players Market Share by Revenue

2.8.3 Global Next-Generation Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Next-Generation Drug-Eluting Stent Market Scenario by Region

3.1 Global Next-Generation Drug-Eluting Stent Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Next-Generation Drug-Eluting Stent Sales by Region: 2020-2031

3.2.1 Global Next-Generation Drug-Eluting Stent Sales by Region: 2020-2025

3.2.2 Global Next-Generation Drug-Eluting Stent Sales by Region: 2026-2031

3.3 Global Next-Generation Drug-Eluting Stent Revenue by Region: 2020-2031

3.3.1 Global Next-Generation Drug-Eluting Stent Revenue by Region: 2020-2025

3.3.2 Global Next-Generation Drug-Eluting Stent Revenue by Region: 2026-2031

3.4 North America Next-Generation Drug-Eluting Stent Market Facts & Figures by Country

3.4.1 North America Next-Generation Drug-Eluting Stent Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Next-Generation Drug-Eluting Stent Sales by Country (2020-2031)

3.4.3 North America Next-Generation Drug-Eluting Stent Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Next-Generation Drug-Eluting Stent Market Facts & Figures by Country

3.5.1 Europe Next-Generation Drug-Eluting Stent Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Next-Generation Drug-Eluting Stent Sales by Country (2020-2031)

3.5.3 Europe Next-Generation Drug-Eluting Stent Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Next-Generation Drug-Eluting Stent Market Facts & Figures by Region

3.6.1 Asia Pacific Next-Generation Drug-Eluting Stent Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Next-Generation Drug-Eluting Stent Sales by Region (2020-2031)

3.6.3 Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Next-Generation Drug-Eluting Stent Market Facts & Figures by Country

3.7.1 Latin America Next-Generation Drug-Eluting Stent Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Next-Generation Drug-Eluting Stent Sales by Country (2020-2031)

3.7.3 Latin America Next-Generation Drug-Eluting Stent Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Next-Generation Drug-Eluting Stent Market Facts & Figures by Country

3.8.1 Middle East and Africa Next-Generation Drug-Eluting Stent Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Country (2020-2031)

3.8.3 Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Next-Generation Drug-Eluting Stent Sales by Type (2020-2031)

4.1.1 Global Next-Generation Drug-Eluting Stent Sales by Type (2020-2025)

4.1.2 Global Next-Generation Drug-Eluting Stent Sales by Type (2026-2031)

4.1.3 Global Next-Generation Drug-Eluting Stent Sales Market Share by Type (2020-2031)

4.2 Global Next-Generation Drug-Eluting Stent Revenue by Type (2020-2031)

4.2.1 Global Next-Generation Drug-Eluting Stent Revenue by Type (2020-2025)

4.2.2 Global Next-Generation Drug-Eluting Stent Revenue by Type (2026-2031)

4.2.3 Global Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2020-2031)

4.3 Global Next-Generation Drug-Eluting Stent Price by Type (2020-2031)

5 Segment by Application

5.1 Global Next-Generation Drug-Eluting Stent Sales by Application (2020-2031)

5.1.1 Global Next-Generation Drug-Eluting Stent Sales by Application (2020-2025)

5.1.2 Global Next-Generation Drug-Eluting Stent Sales by Application (2026-2031)

5.1.3 Global Next-Generation Drug-Eluting Stent Sales Market Share by Application (2020-2031)

5.2 Global Next-Generation Drug-Eluting Stent Revenue by Application (2020-2031)

5.2.1 Global Next-Generation Drug-Eluting Stent Revenue by Application (2020-2025)

5.2.2 Global Next-Generation Drug-Eluting Stent Revenue by Application (2026-2031)

5.2.3 Global Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2020-2031)

5.3 Global Next-Generation Drug-Eluting Stent Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Abbott

6.1.1 Abbott Company Information

6.1.2 Abbott Description and Business Overview

6.1.3 Abbott Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Abbott Next-Generation Drug-Eluting Stent Product Portfolio

6.1.5 Abbott Recent Developments/Updates

6.2 Biosensors International

6.2.1 Biosensors International Company Information

6.2.2 Biosensors International Description and Business Overview

6.2.3 Biosensors International Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Biosensors International Next-Generation Drug-Eluting Stent Product Portfolio

6.2.5 Biosensors International Recent Developments/Updates

6.3 Medtronic

6.3.1 Medtronic Company Information

6.3.2 Medtronic Description and Business Overview

6.3.3 Medtronic Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Medtronic Next-Generation Drug-Eluting Stent Product Portfolio

6.3.5 Medtronic Recent Developments/Updates

6.4 Sorin Group

6.4.1 Sorin Group Company Information

6.4.2 Sorin Group Description and Business Overview

6.4.3 Sorin Group Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Sorin Group Next-Generation Drug-Eluting Stent Product Portfolio

6.4.5 Sorin Group Recent Developments/Updates

6.5 SMT

6.5.1 SMT Company Information

6.5.2 SMT Description and Business Overview

6.5.3 SMT Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)

6.5.4 SMT Next-Generation Drug-Eluting Stent Product Portfolio

6.5.5 SMT Recent Developments/Updates

6.6 Terumo

6.6.1 Terumo Company Information

6.6.2 Terumo Description and Business Overview

6.6.3 Terumo Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Terumo Next-Generation Drug-Eluting Stent Product Portfolio

6.6.5 Terumo Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Next-Generation Drug-Eluting Stent Industry Chain Analysis

7.2 Next-Generation Drug-Eluting Stent Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Next-Generation Drug-Eluting Stent Production Mode & Process Analysis

7.4 Next-Generation Drug-Eluting Stent Sales and Marketing

7.4.1 Next-Generation Drug-Eluting Stent Sales Channels

7.4.2 Next-Generation Drug-Eluting Stent Distributors

7.5 Next-Generation Drug-Eluting Stent Customer Analysis

8 Next-Generation Drug-Eluting Stent Market Dynamics

8.1 Next-Generation Drug-Eluting Stent Industry Trends

8.2 Next-Generation Drug-Eluting Stent Market Drivers

8.3 Next-Generation Drug-Eluting Stent Market Challenges

8.4 Next-Generation Drug-Eluting Stent Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Abbott

Biosensors International

List of Tables

Table 1. Global Next-Generation Drug-Eluting Stent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Next-Generation Drug-Eluting Stent Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Next-Generation Drug-Eluting Stent Market Competitive Situation by Manufacturers in 2024

Table 4. Global Next-Generation Drug-Eluting Stent Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Next-Generation Drug-Eluting Stent Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Next-Generation Drug-Eluting Stent Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Next-Generation Drug-Eluting Stent Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Next-Generation Drug-Eluting Stent Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Next-Generation Drug-Eluting Stent, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Next-Generation Drug-Eluting Stent, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Next-Generation Drug-Eluting Stent, Product Type & Application

Table 12. Global Key Manufacturers of Next-Generation Drug-Eluting Stent, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Next-Generation Drug-Eluting Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Drug-Eluting Stent as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Next-Generation Drug-Eluting Stent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Next-Generation Drug-Eluting Stent Sales by Region (2020-2025) & (K Units)

Table 18. Global Next-Generation Drug-Eluting Stent Sales Market Share by Region (2020-2025)

Table 19. Global Next-Generation Drug-Eluting Stent Sales by Region (2026-2031) & (K Units)

Table 20. Global Next-Generation Drug-Eluting Stent Sales Market Share by Region (2026-2031)

Table 21. Global Next-Generation Drug-Eluting Stent Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Region (2020-2025)

Table 23. Global Next-Generation Drug-Eluting Stent Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Region (2026-2031)

Table 25. North America Next-Generation Drug-Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Next-Generation Drug-Eluting Stent Sales by Country (2020-2025) & (K Units)

Table 27. North America Next-Generation Drug-Eluting Stent Sales by Country (2026-2031) & (K Units)

Table 28. North America Next-Generation Drug-Eluting Stent Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Next-Generation Drug-Eluting Stent Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Next-Generation Drug-Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Next-Generation Drug-Eluting Stent Sales by Country (2020-2025) & (K Units)

Table 32. Europe Next-Generation Drug-Eluting Stent Sales by Country (2026-2031) & (K Units)

Table 33. Europe Next-Generation Drug-Eluting Stent Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Next-Generation Drug-Eluting Stent Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Next-Generation Drug-Eluting Stent Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Next-Generation Drug-Eluting Stent Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Next-Generation Drug-Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Next-Generation Drug-Eluting Stent Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Next-Generation Drug-Eluting Stent Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Next-Generation Drug-Eluting Stent Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Next-Generation Drug-Eluting Stent Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Next-Generation Drug-Eluting Stent Sales (K Units) by Type (2020-2025)

Table 51. Global Next-Generation Drug-Eluting Stent Sales (K Units) by Type (2026-2031)

Table 52. Global Next-Generation Drug-Eluting Stent Sales Market Share by Type (2020-2025)

Table 53. Global Next-Generation Drug-Eluting Stent Sales Market Share by Type (2026-2031)

Table 54. Global Next-Generation Drug-Eluting Stent Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Next-Generation Drug-Eluting Stent Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2020-2025)

Table 57. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2026-2031)

Table 58. Global Next-Generation Drug-Eluting Stent Price (USD/Unit) by Type (2020-2025)

Table 59. Global Next-Generation Drug-Eluting Stent Price (USD/Unit) by Type (2026-2031)

Table 60. Global Next-Generation Drug-Eluting Stent Sales (K Units) by Application (2020-2025)

Table 61. Global Next-Generation Drug-Eluting Stent Sales (K Units) by Application (2026-2031)

Table 62. Global Next-Generation Drug-Eluting Stent Sales Market Share by Application (2020-2025)

Table 63. Global Next-Generation Drug-Eluting Stent Sales Market Share by Application (2026-2031)

Table 64. Global Next-Generation Drug-Eluting Stent Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Next-Generation Drug-Eluting Stent Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2020-2025)

Table 67. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2026-2031)

Table 68. Global Next-Generation Drug-Eluting Stent Price (USD/Unit) by Application (2020-2025)

Table 69. Global Next-Generation Drug-Eluting Stent Price (USD/Unit) by Application (2026-2031)

Table 70. Abbott Company Information

Table 71. Abbott Description and Business Overview

Table 72. Abbott Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Abbott Next-Generation Drug-Eluting Stent Product

Table 74. Abbott Recent Developments/Updates

Table 75. Biosensors International Company Information

Table 76. Biosensors International Description and Business Overview

Table 77. Biosensors International Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Biosensors International Next-Generation Drug-Eluting Stent Product

Table 79. Biosensors International Recent Developments/Updates

Table 80. Medtronic Company Information

Table 81. Medtronic Description and Business Overview

Table 82. Medtronic Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Medtronic Next-Generation Drug-Eluting Stent Product

Table 84. Medtronic Recent Developments/Updates

Table 85. Sorin Group Company Information

Table 86. Sorin Group Description and Business Overview

Table 87. Sorin Group Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Sorin Group Next-Generation Drug-Eluting Stent Product

Table 89. Sorin Group Recent Developments/Updates

Table 90. SMT Company Information

Table 91. SMT Description and Business Overview

Table 92. SMT Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. SMT Next-Generation Drug-Eluting Stent Product

Table 94. SMT Recent Developments/Updates

Table 95. Terumo Company Information

Table 96. Terumo Description and Business Overview

Table 97. Terumo Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Terumo Next-Generation Drug-Eluting Stent Product

Table 99. Terumo Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Next-Generation Drug-Eluting Stent Distributors List

Table 103. Next-Generation Drug-Eluting Stent Customers List

Table 104. Next-Generation Drug-Eluting Stent Market Trends

Table 105. Next-Generation Drug-Eluting Stent Market Drivers

Table 106. Next-Generation Drug-Eluting Stent Market Challenges

Table 107. Next-Generation Drug-Eluting Stent Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Next-Generation Drug-Eluting Stent

Figure 2. Global Next-Generation Drug-Eluting Stent Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Next-Generation Drug-Eluting Stent Market Share by Type: 2024 & 2031

Figure 4. Cobalt Chromium Product Picture

Figure 5. Stainless Steel Product Picture

Figure 6. Others Product Picture

Figure 7. Global Next-Generation Drug-Eluting Stent Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Next-Generation Drug-Eluting Stent Market Share by Application: 2024 & 2031

Figure 9. Hospitals

Figure 10. Clinics

Figure 11. Ambulatory Surgical Centers

Figure 12. Global Next-Generation Drug-Eluting Stent Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Next-Generation Drug-Eluting Stent Market Size (2020-2031) & (US$ Million)

Figure 14. Global Next-Generation Drug-Eluting Stent Sales (2020-2031) & (K Units)

Figure 15. Global Next-Generation Drug-Eluting Stent Average Price (USD/Unit) & (2020-2031)

Figure 16. Next-Generation Drug-Eluting Stent Report Years Considered

Figure 17. Next-Generation Drug-Eluting Stent Sales Share by Manufacturers in 2024

Figure 18. Global Next-Generation Drug-Eluting Stent Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Next-Generation Drug-Eluting Stent Players: Market Share by Revenue in Next-Generation Drug-Eluting Stent in 2024

Figure 20. Next-Generation Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Next-Generation Drug-Eluting Stent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Next-Generation Drug-Eluting Stent Sales Market Share by Country (2020-2031)

Figure 23. North America Next-Generation Drug-Eluting Stent Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Next-Generation Drug-Eluting Stent Sales Market Share by Country (2020-2031)

Figure 27. Europe Next-Generation Drug-Eluting Stent Revenue Market Share by Country (2020-2031)

Figure 28. Germany Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Next-Generation Drug-Eluting Stent Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Next-Generation Drug-Eluting Stent Revenue Market Share by Region (2020-2031)

Figure 35. China Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Next-Generation Drug-Eluting Stent Sales Market Share by Country (2020-2031)

Figure 46. Latin America Next-Generation Drug-Eluting Stent Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Next-Generation Drug-Eluting Stent Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Next-Generation Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Next-Generation Drug-Eluting Stent by Type (2020-2031)

Figure 56. Global Revenue Market Share of Next-Generation Drug-Eluting Stent by Type (2020-2031)

Figure 57. Global Next-Generation Drug-Eluting Stent Price (USD/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Next-Generation Drug-Eluting Stent by Application (2020-2031)

Figure 59. Global Revenue Market Share of Next-Generation Drug-Eluting Stent by Application (2020-2031)

Figure 60. Global Next-Generation Drug-Eluting Stent Price (USD/Unit) by Application (2020-2031)

Figure 61. Next-Generation Drug-Eluting Stent Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cobalt Chromium Coronary Stent Market Research Report 2024

Global Drug Eluting Coronary Stent System Market Research Report 2024

Global Drug eluting Coronary Stents Market Research Report 2025

Global Sirolimus Eluting Coronary Stent Market Research Report 2025

Drug Eluting Stent System Market

Global Implantable Coronary Drug Eluting Stent Market Research Report 2024

Global Implantable Drug Eluting Stent Market Research Report 2024

Global Coronary Drug Eluting Stent Market Research Report 2024

Global Biodegradable Drug Eluting Stents Market Research Report 2024

Global Peripheral Drug Eluting Stent Market Research Report 2025

Global Drug Coated Stent System Market Research Report 2024

Global Medical Coronary Drug Eluting Stent Market Research Report 2024

Global Heart Stents Market Insights Forecast to 2030

Global Bare Metal Stents Market Insights Forecast to 2030

Coronary Intervention Drug Eluting Stent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cardiovascular Drug Eluting Stents DES Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bioresorbable Drug Eluting Stents Market Research Report 2025

Global Coronary Drug Stent System Market Research Report 2024

Global Bioabsorbable Eluting Coronary Stent System Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions